Healthcare -
Biotechnology - NASDAQ - US
$ 3.12
-8.5 %
$ 529 M
Market Cap
-1.32
P/E
Price Target
Average
498.29%
Revenue Forecast
Estimate
81.55%
EBIT
Estimate
39.70%
Net Income
Estimate
15.50%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Relay Therapeutics, Inc.
Wall Street analysts predict an average 1-year price target for RLAY of $18.7 , with forecasts ranging from
a
low of
$15 to a high of $25 .
RLAY Lowest Price Target
Wall Street Target
15 USD
380.77%
RLAY Average Price Target
Wall Street Target
18.7 USD
498.29%
RLAY Highest Price Target
Wall Street Target
25 USD
701.28%
REVENUE FORECAST
Revenue Forecast Chart RLAY
EBIT FORECAST
EBIT Forecast Chart RLAY
NET INCOME FORECAST
Net Income Chart RLAY